CROSSLIFE TECHNOLOGIES INC.
Carlsbad, CA · Medtech · Private
Point-of-care HPV 16/18/45 DNA diagnostic test on a paper-strip device with novel probe chemistry requiring no sample preparation
crosslifetech.com →- Grants
- $18M
- 28 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $966K
- 4 awards · Health and Human S
- #322 of 4531 in medtech
- Patents
- 11
- 3 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection | $305,232 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection | $345,232 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection | $40,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Rapid RNA Diagnosis of Influenza Virus | $306,564 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Rapid RNA Diagnosis of Influenza Virus | $306,564 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Rapid RNA test for HIV | $281,515 | |
| Federal grant· 1 of 3 same day | Department of Health and Human Services · Phase I · A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care | $282,084 | |
| Federal grant· 2 of 3 same day | Department of Health and Human Services · Phase I · A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care | $282,084 | |
| Federal grant· 3 of 3 same day | Department of Health and Human Services · Phase I · Point-of-Care Rapid RNA test for HIV | $281,515 | |
| Federal grant | Department of Health and Human Services · Phase I · A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus | $299,574 | |
| Federal grant | Department of Health and Human Services · Phase I · A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus | $299,574 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Rapid, instrument-free Nucleic Acid Test for Pathogens and Biothreats | $224,929 | |
| Federal contract | Department of Health and Human Services · Diagnostics To Enable Malaria And Neglected Tropical Diseases | $216,444 | |
| Federal contract | Department of Health and Human Services · SBIR Phase I Igf::otigf | $149,956 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-Care Rapid RNA test for HIV | $999,743 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Point-of-Care RNA Diagnostic for Dengue Infection | $299,410 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Multiplexed Point-Of-Care Molecular Detection of Respiratory Pathogens without Sample Prep | $299,766 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-Care Rapid RNA test for HIV | $995,819 | |
| Federal contract | Department of Health and Human Services · Purpose: Contract Award For SBIR Topic 073 Phase I "a Rapid Nucleic Acid Test For The Point Of Care Detection Of Malaria" In The Amount Of $299,974. | $299,974 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Point-of-Care Nucleic Acid Test for HCV | $999,841 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Point-of-Care Nucleic Acid Test for HCV | $1,990,281 | |
| Federal contract | Department of Health and Human Services · Point Of Care Nucleic Acids Test For The Liver Flukes Opisthorchis Viverrini And Clonorchis | $299,987 | |
| Federal grant | Department of Health and Human Services · Phase II · Point of Care HPV 16/18/45 DNA Test for Cervical Cancer | $299,945 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Point-of-Care Nucleic Acid Test for HCV | $990,440 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-Care Rapid RNA test for Zika | $999,916 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Rapid Point-of-Care RNA Diagnostic for Dengue Infection | $999,799 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Rapid Point-of-Care RNA Diagnostic for Dengue Infection | $1,999,598 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Point-of-Care RNA Diagnostic for Dengue Infection | $999,799 | |
| Federal grant | Department of Health and Human Services · Phase II · Point of Care HPV 16/18/45 DNA Test for Cervical Cancer | $994,004 | |
| Federal grant | Department of Health and Human Services · Phase II · Point of Care HPV 16/18/45 DNA Test for Cervical Cancer | $994,004 | |
| Federal grant | Department of Health and Human Services · Phase II · Point of Care HPV 16/18/45 DNA Test for Cervical Cancer | $994,439 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 319 | ZETROZ SYSTEMS LLC | $1000K | — |
| 320 | Caregility Corp | $997K | $7.5M |
| 321 | ARETE BIOSCIENCES | $995K | — |
| 322 | CROSSLIFE TECHNOLOGIES INC. | $966K | — |
| 323 | SHOULDER INNOVATIONS, INC. | $966K | $81M |
| 324 | Securisyn Medical, LLC | $958K | $11M |
| 325 | Xoran Technologies LLC | $957K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Engineered Therapeutic PROTEIMER Compositions and Related Methodsapplication
- Engineered Gyri-like Mutein Aptamers, And Related Methodsapplication
- Engineered Gyri-like Mutein Aptamers, And Related Methodsgranted
- Rapid Nucleic Acid Detection Without Sample Preparationgranted
- Methods And Compositions Of Non-enzymatic Amplification And Direct Detection Of Nucleic Acidsgranted
- Engineered Therapeutic Proteimer Compositions And Related Methodsapplication
- Rapid Nucleic Acid Detection Without Sample Preparationapplication
- Engineered Gyri-like Mutein Aptamers, And Related Methodsapplication
- Design And Engineering Of Organic Molecule-binding Aptamers Using The Gyri-like Family Of Proteins As A Scaffoldapplication
- Rapid Nucleic Acid Detectionapplication
- Engineered Therapeutic Proteimer Compositions and Related Methodsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.